IPV

Polio vaccination: past, present and future.

Auteur: Katherine Seib, Ananda S. Bandyopadhyay, Julie Garon, Walter A Orenstein

The power of straight talk

Auteur: Nellie Bristol, Chris Millard

Global Vaccine Action Plan Secretariat Annual Report 2015

Auteur: World Health Organization (WHO)

March 2019 VIEW-hub Report: Global Vaccine Introduction and Implementation

Auteur: International Vaccine Access Center (IVAC)

December 2018 VIEW-hub Report on Global Introduction and Implementation

Auteur: International Vaccine Access Center (IVAC)

September 2018 VIEW-hub Report: Global Vaccine Introduction and Implementation

Auteur: International Vaccine Access Center (IVAC)

June 2018 VIEW-hub Report on Global Introduction and Implementation

Auteur: International Vaccine Access Center (IVAC)

Report from the Seventeenth Meeting Global Commission for the Certification of the Eradication of Poliomyelitis

Auteur: World Health Organization (WHO)

Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the NanopatchTM Microprojection Array

Auteur: YingWan et al.

December 2017 VIEW-hub Report on Global Introduction and Implementation

Auteur: International Vaccine Access Center (IVAC)

Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio

Auteur: Lee M. Hampton et al.

Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes

Auteur: Kimberly M. Thompson et al.

Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission

Auteur: Kimberly M. Thompson et al.

Monitoring and Validation of the Global Replacement of tOPV with bOPV, April–May 2016

Auteur: Margaret Farrell et al.

Administering Multiple Injectable Vaccines During a Single Visit—Summary of Findings From the Accelerated Introduction of Inactivated Polio Vaccine Globally

Auteur: Samantha B. Dolan et al.

Acceptance of the Administration of Multiple Injectable Vaccines in a Single Immunization Visit in Albania

Auteur: Iria Preza et al.

Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria

Auteur: Soleine Scotney et al.

Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April–November 2015

Auteur: Lynda U. Osadebe et al.

Cold-Chain Adaptability During Introduction of Inactivated Polio Vaccine in Bangladesh, 2015

Auteur: Mallick M. Billah et al.

The Role of National Immunization Technical Advisory Groups (NITAGs) in the Introduction of Inactivated Polio Vaccine: Experience of the Indonesia and Uganda NITAGs

Auteur: Toto Wisnu Hendrarto, Nelson K. Sewankambo, Celia Nalwadda, Annette Kisakye, Antoinette Ba-Nguz, Alex Adjagba

Experience With Inactivated Polio Vaccine Introduction and the “Switch” From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization’s Western Pacific Region

Auteur: Santosh Gurung et al.

The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region

Auteur: Sunil Bahl et al.

Introduction of Inactivated Polio Vaccine, Withdrawal of Type 2 Oral Polio Vaccine, and Routine Immunization Strengthening in the Eastern Mediterranean Region

Auteur: Kamal Fahmy et al.

June 2017 VIEW-hub Report on Global Introduction and Implementation

Auteur: International Vaccine Access Center (IVAC)

Exceptional financial support for introduction of Inactivated Polio Vaccine in middle-income countries

Auteur: Anne-Line Blankenhorn, Tania Cernuschi, Michel J. Zaffran

Managing the planned cessation of a global supply market: Lessons learned from the global cessation of the trivalent Oral Poliovirus Vaccine market

Auteur: Jennifer Rubin et al.

A supply and demand management perspective on the accelerated global introductions of Inactivated Poliovirus Vaccine in a constrained supply market

Auteur: Ian Lewis et al.

Communications, immunization, and polio vaccines: Lessons from a global perspective on generating political will, informing decision-making and planning, and engaging local support

Auteur: Lisa Menning et al.

Lessons learned from managing the planning and implementation of inactivated polio vaccine introduction in support of the polio endgame

Auteur: Simona Zipursky et al.

Polio endgame: Lessons learned from the Immunization Systems Management Group

Auteur: Simona Zipursky et al.

Progress toward containment of poliovirus Type 2 — worldwide, 2017

Auteur: Nicoletta Previsani et al.

VIEW-hub Report

Auteur: International Vaccine Access Center (IVAC)

First-in-human safety and immunogenicity investigations of 3 adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster to adolescents with a history of IPV vaccination

Auteur: Line M. Lindgren et al.

Guidance for assessment of poliovirus vaccination status and vaccination of children who have received poliovirus vaccine outside the United States

Auteur: Mona Marin et al.

Wild and vaccine-derived poliovirus circulation, and implications for polio eradication

Auteur: P. L. Lopalco

Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants

Auteur: Peter F Wright et al.

Polio endgame, information gaps related to vaccines and immunity

Auteur: Mohammad Ahmad, Abhishek Kunwar, Sunil Bahl

India's preparedness for introduction of IPV and switch from tOPV to bOPV

Auteur: Pankaj Agrawal, Pradeep Haldar

September 2016 VIEW-hub Report on Global Introduction and Implementation

Auteur: International Vaccine Access Center (IVAC)

Population immunity against serotype-2 poliomyelitis leading up to the global withdrawal of the oral poliovirus vaccine: Spatio-temporal modelling of surveillance data

Auteur: Margarita Pons-Salort et al.

The need and potential of Inactivated Poliovirus Vaccine

Auteur: Julie Garon et al.

Fractional-dose inactivated poliovirus vaccination campaign, Telangana state, India, June 2016

Auteur: Sunil Bahl et al.

June 2016 VIEW-hub Report on Global Introduction and Implementation

Auteur: International Vaccine Access Center (IVAC)

The importance of social networking in a national polio vaccine Campaign

Auteur: Keren Landsman, Lisa Rubin

Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial

Auteur: Jacob John et al.

The potential impact of routine immunization with inactivated poliovirus vaccine on wild-type or Vaccine-derived Poliovirus Outbreaks in a post-eradication setting

Auteur: Mangal TD et al.

Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities — Kenya, December 2013

Auteur: Mohamed A Sheikh et al.

afety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP–IPV) vaccine

Auteur: Matthew F. Daley et al.

Making history: from a public health emergency to a polio-free world

Auteur: R Bruce Aylward

Circulating vaccine-derived poliovirus outbreaks in 5 countries, 2014–2015

Auteur: Michelle Morales et al.

Priming after a fractional dose of inactivated poliovirus vaccine

Auteur: Resik S et al.

The effect of mass immunisation campaigns and new oral poliovirus vaccines of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis

Auteur: Kathleen M O\'Reilly et al.

Polio in Nigeria: The race to eradication

Auteur: Farha Tahir, Jennifer G. Cooke

Inactivated polio vaccine and global polio eradication

Auteur: John F Modlin

Why is Pakistan a threat to ‘‘The Polio Eradication and Endgame Strategic Plan 2013–2018’’? A look into the past decade

The last mile in global poliomyelitis eradication

Auteur: Zulfiqar A. Bhutta

A worldwide shift in polio vaccines for routine immunisation

Auteur: Walter A Orenstein, Julie R. Garon

Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial

Auteur: Roland W Sutter et al.

Introduction of inactivated poliovirus vaccine and switch from trivalent to bivalent oral poliovirus vaccine — Worldwide, 2013–2016

Auteur: Centers for Disease Control and Prevention (CDC)

Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants

Auteur: Verdijk P et al.

The budget impact of controlling wastage with smaller vials: A data driven model of session sizes in Bangladesh, India (Uttar Pradesh), Mozambique, and Uganda

Auteur: Wanfei Yang et al.

The challenge of changing the inactivated poliomyelitis vaccine in Latin America. Declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE)

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies

Auteur: Sonia Resik et al.

Alternative delivery of a thermostable inactivated polio vaccine

Auteur: Kraan H et al.

Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study

Auteur: Miguel O\'Ryan et al.

Introduction of inactivated polio vaccine and specific determinants of vaccine hesitancy

Auteur: Maduka Donatus Ughasoro et al.

Case Studies of IPV introduction: Albania, Nigeria, and Tunisia

Auteur: International Vaccine Access Center (IVAC)

Mots-clés

Du Centre de connaissances

Membres de Technet-21

Événements à venir

Messages de forum récents

Offres d'emploi

Du blog

Thèmes

About

Knowledge Hub

Community

More